Vilon

Vilon is a short peptide that helps the body maintain strong immune balance and cellular health. It supports tissue repair, healthy aging, and immune stability, and has been studied for decades as part of thymic peptide therapy research in Russia.

Description

• Vilon is a dipeptide composed of lysine and glutamic acid (Lys–Glu).
• Developed at the St. Petersburg Institute of Bioregulation and Gerontology as a natural thymic peptide regulator.
• Recognized for its immunoregulatory and gene-modulating properties that promote cellular repair and longevity.

How It Works

• Regulates gene expression involved in protein synthesis and cell differentiation.
• Normalizes thymus, endocrine, and nervous system function under stress or aging.
• Acts on nuclear DNA and chromatin to restore cellular metabolism and immune competence.

Documented Effects

• Restores thymic activity and T-cell formation in clinical and animal studies.
• Improves immune resilience, tissue regeneration, and response to stress.
• Supports balanced hormone function and metabolic recovery during aging.
• Shown to increase lifespan and reduce disease incidence in aging models.

Theoretical Effects

• Potential anti-aging and immune-restoring effects through direct gene regulation.
• May enhance thymic rejuvenation when combined with Thymalin or Epitalon.
• Possible influence on DNA repair, telomerase activity, and oxidative stress defense.

Pharmacokinetics

• Half-life: approximately 30–60 minutes post-injection.
• Onset: systemic immune and cellular effects within several days of dosing.
• Duration: gene expression modulation may persist for weeks after a short cycle.

Reconstitution

• Use only bacteriostatic water for reconstitution.
• Example vial: 10 mg Vilon
• Choose reconstitution volume based on dosing convenience:
  • 1 mL water → 10 mg/mL → 1 mg per 10 units
  • 2 mL water → 5 mg/mL → 500 mcg per 10 units
  • 4 mL water → 2.5 mg/mL → 250 mcg per 10 units
• Swirl gently to dissolve; avoid shaking or heat exposure.
• Refrigerate reconstituted solution (2–8 °C). Use within ~30 days for best stability.

Injectable Dosage Overview (Clinical and Research Reference)

Typical Clinical Dose (Russia)

• 1–10 mg intramuscular (IM) daily for 10 days, depending on immune or endocrine function.
• Cycles are typically repeated every 3–6 months for maintenance or prevention.

Common Research Range

• 2–5 mg subcutaneous (SC) or IM daily for 10 consecutive days.
• Used to study immune normalization, neuroendocrine balance, and cell repair mechanisms.

Maximum Daily Dose

• Clinical use rarely exceeds 10 mg per day.
• Higher doses have not shown added benefit and are not well-studied long term.

Standard Cycle Length

• Typical course: 10 days for immune or endocrine normalization.
• Maintenance: every 3–6 months to sustain benefits.

Clinical Notes

• Administered subcutaneously or intramuscularly; rotate injection sites to minimize local irritation.
• Used for immune regulation, cellular repair support, and reduction of chronic inflammatory load.
• Often taken in short therapeutic cycles (5–10 days), similar to other thymic peptides.
• Generally well-tolerated; mild fatigue or warmth shortly after injection may occur.
• Can be combined with Thymalin or Thymosin Alpha-1 for synergistic immune-support protocols.
• Stable for about 30 days when refrigerated (2–8°C). Protect from light and heat. Avoid freezing.

Safety Notes

• Clinically used in Russia for over 30 years with an excellent safety record.
• No major side effects reported aside from mild soreness at injection site.
• Derived from natural peptide sequences; rapidly metabolized and excreted.
• For regulated research or clinical environments; not approved for general medical use in most countries.